Solara Active Pharma Sciences Ltd. Share Price

Solara Active Pharma Sciences has informed that pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) and Regulation 10(c) of Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, (‘SEBI SBEB & SE Regulations’), the Board of Directors have approved the allotment of 2,200 Equity Shares of face value Rs 10 each fully paid up against the exercise of vested Options of Solara Employee Stock Option Plan 2018. The equity shares so allotted under the aforesaid Scheme, shall rank with the existing equity shares of the Company in all respects. Consequent to the aforesaid allotment, the paid‐up share capital of the Company will accordingly increase, as details enclosed. In terms of Regulation 10(c) read with Part - E of the SEBI SBEB & SE Regulations, the details of the shares allotted are enclosed as ‘Annexure-A; and the details required as per Master circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as ‘Annexure -B’.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Sciences has informed that the Company has scheduled a conference call with analysts/ investors to discuss Company’s audited financial results for the quarter and financial year ended March 31, 2026 on Friday, May 15, 2026 at 03:00 pm (IST). Analysts / Investors Conference Call details are enclosed. Further, the above information will also be available on the website of the Company: https://solara.co.in/investor-relations/schedule-of-investors-meet-and-investors-presentations.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Sciences has informed that the Meeting of the Rights Issue Committee of the Board of Directors of the Company held today, Tuesday, March 24, 2026 has considered and approved the making of Second & Final call of ₹ 112.50/- per equity shares (₹ 3.00/- towards face value and ₹ 109.50/- towards securities premium) per Rights Share in respect of partly-paid Rights Shares, on Rights basis, pursuant to the Letter of Offer dated May 09, 2024. Rights Issue Committee has fixed Thursday, April 02, 2026, as the Record date for the purpose of determining the holders of partly paid-up Equity Shares to whom the call notice will be dispatched for payment of the call. Details under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 has been enclosed as Annexure I. The Rights Issue Committee Meeting commenced at 9.30 am and concluded at 9.55 am.

The above information is a part of company’s filings submitted to BSE.

Pursuant to the provisions of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 (‘SEBI Listing Regulations’) Fortis Malar Hospitals has informed that the Board of Directors of the Company at its meeting held today, Monday, May 18, 2026, considered and approved the following: - 1. Financial Results: Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026 along with Statement of Assets and Liabilities as on March 31, 2026. B S R & Co. LLP, the Statutory Auditors of the Company have issued an Audit Report with an unmodified opinion on the Standalone and Consolidated Financial Statements. Accordingly, the standalone and consolidated audited financial results, auditors’ reports, Statement of Assets & Liabilities, and declaration pursuant to Regulation 33(3)(d) of the SEBI Listing Regulations, regarding Unmodified Opinion on the Audited financial results for the financial year ended March 31, 2026 are enclosed; 2. Adoption of Policies: a. The modification in the policy for the determination of Materiality of Events/Information, which also contains the details of persons authorized to determine the Materiality of the Event/Information for the purpose of disclosures to Stock Exchange. The said revised policy has been enclosed. b. The updated Policy/Code of Conduct for the prevention of Insider Trading. The said updated policy/Code has also been enclosed. The Board Meeting commenced at 11:30 am (IST) and concluded at 03:35 pm (IST). The same is also uploaded on the website of the Company.

The above information is a part of company’s filings submitted to BSE.